[PETDAG] QoQ Annualized Quarter Result on 31-Dec-2019 [#4]

Announcement Date
25-Feb-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Dec-2019 [#4]
Profit Trend
QoQ- -11.49%
YoY- -2.39%
View:
Show?
Annualized Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 19,088,185 18,971,322 26,215,640 30,293,571 29,999,149 29,384,268 28,343,620 -23.11%
PBT 361,373 -34,522 -73,712 1,128,872 1,251,073 1,241,228 1,531,944 -61.72%
Tax -115,012 -17,532 -37,088 -291,237 -306,442 -305,302 -357,608 -52.96%
NP 246,361 -52,054 -110,800 837,635 944,630 935,926 1,174,336 -64.59%
-
NP to SH 249,000 -51,822 -117,692 829,535 937,264 927,894 1,164,784 -64.14%
-
Tax Rate 31.83% - - 25.80% 24.49% 24.60% 23.34% -
Total Cost 18,841,824 19,023,376 26,326,440 29,455,936 29,054,518 28,448,342 27,169,284 -21.59%
-
Net Worth 5,662,687 5,503,735 5,553,408 5,980,593 6,010,396 5,911,051 5,871,312 -2.37%
Dividend
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Div 278,167 198,690 198,690 844,435 596,072 576,203 596,072 -39.75%
Div Payout % 111.71% 0.00% 0.00% 101.80% 63.60% 62.10% 51.17% -
Equity
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Net Worth 5,662,687 5,503,735 5,553,408 5,980,593 6,010,396 5,911,051 5,871,312 -2.37%
NOSH 993,454 993,454 993,454 993,454 993,454 993,454 993,454 0.00%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin 1.29% -0.27% -0.42% 2.77% 3.15% 3.19% 4.14% -
ROE 4.40% -0.94% -2.12% 13.87% 15.59% 15.70% 19.84% -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
RPS 1,921.40 1,909.63 2,638.84 3,049.32 3,019.68 2,957.79 2,853.04 -23.11%
EPS 25.07 -5.20 -12.00 83.50 94.40 93.40 117.20 -64.13%
DPS 28.00 20.00 20.00 85.00 60.00 58.00 60.00 -39.75%
NAPS 5.70 5.54 5.59 6.02 6.05 5.95 5.91 -2.37%
Adjusted Per Share Value based on latest NOSH - 993,454
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
RPS 1,921.40 1,909.63 2,638.84 3,049.32 3,019.68 2,957.79 2,853.04 -23.11%
EPS 25.07 -5.20 -12.00 83.50 94.40 93.40 117.20 -64.13%
DPS 28.00 20.00 20.00 85.00 60.00 58.00 60.00 -39.75%
NAPS 5.70 5.54 5.59 6.02 6.05 5.95 5.91 -2.37%
Price Multiplier on Financial Quarter End Date
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Date 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 -
Price 19.74 20.60 21.16 23.10 23.60 25.40 25.00 -
P/RPS 1.03 1.08 0.80 0.76 0.78 0.86 0.88 11.03%
P/EPS 78.76 -394.91 -178.61 27.66 25.01 27.19 21.32 138.40%
EY 1.27 -0.25 -0.56 3.61 4.00 3.68 4.69 -58.04%
DY 1.42 0.97 0.95 3.68 2.54 2.28 2.40 -29.45%
P/NAPS 3.46 3.72 3.79 3.84 3.90 4.27 4.23 -12.50%
Price Multiplier on Announcement Date
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Date 17/11/20 25/08/20 19/05/20 25/02/20 22/11/19 23/08/19 28/05/19 -
Price 19.50 21.22 20.22 21.40 24.10 23.26 24.72 -
P/RPS 1.01 1.11 0.77 0.70 0.80 0.79 0.87 10.42%
P/EPS 77.80 -406.80 -170.68 25.63 25.54 24.90 21.08 138.25%
EY 1.29 -0.25 -0.59 3.90 3.91 4.02 4.74 -57.90%
DY 1.44 0.94 0.99 3.97 2.49 2.49 2.43 -29.38%
P/NAPS 3.42 3.83 3.62 3.55 3.98 3.91 4.18 -12.48%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment